Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development
2011
Mst1/2 Signalling to Yap: Gatekeeper for Liver Size and Tumour Development
publication
Evidence: high
Author Information
Author(s): Avruch J, Zhou D, Fitamant J, Bardeesy N
Primary Institution: Massachusetts General Hospital
Hypothesis
The study investigates the role of Mst1/2 signalling in regulating liver size and its implications for tumor development.
Conclusion
Mst1 and Mst2 function as critical tumor suppressors in the liver, and their inactivation leads to liver overgrowth and cancer.
Supporting Evidence
- The Hippo signalling pathway is crucial for liver growth control.
- Defects in Mst1/2 lead to liver overgrowth and cancer.
- Yap is identified as an oncogene in liver cancer.
- Studies show that Mst1 and Mst2 are essential for maintaining hepatocyte quiescence.
Takeaway
This study shows that certain proteins help control how big the liver can grow, and when these proteins don't work right, it can lead to liver cancer.
Methodology
The study reviews recent findings on the Hippo signalling pathway and its components in liver biology and cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website